These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31150698)

  • 1. Effects of Buffer Composition on Site-Specific Glycation of Lysine Residues in Monoclonal Antibodies.
    Jacobitz AW; Dykstra AB; Spahr C; Agrawal NJ
    J Pharm Sci; 2020 Jan; 109(1):293-300. PubMed ID: 31150698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of site-specific glycation during process development of a human therapeutic monoclonal antibody.
    Miller AK; Hambly DM; Kerwin BA; Treuheit MJ; Gadgil HS
    J Pharm Sci; 2011 Jul; 100(7):2543-50. PubMed ID: 21287557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycation during storage and administration of monoclonal antibody formulations.
    Fischer S; Hoernschemeyer J; Mahler HC
    Eur J Pharm Biopharm; 2008 Sep; 70(1):42-50. PubMed ID: 18583113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LC/MS analysis of glycation of IgG molecules in sucrose containing formulations.
    Gadgil HS; Bondarenko PV; Pipes G; Rehder D; McAuley A; Perico N; Dillon T; Ricci M; Treuheit M
    J Pharm Sci; 2007 Oct; 96(10):2607-21. PubMed ID: 17621682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of amino acid residues responsible for the release of free drug from an antibody-drug conjugate utilizing lysine-succinimidyl ester chemistry.
    Chih HW; Gikanga B; Yang Y; Zhang B
    J Pharm Sci; 2011 Jul; 100(7):2518-25. PubMed ID: 21294129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phosphate on the kinetics and specificity of glycation of protein.
    Watkins NG; Neglia-Fisher CI; Dyer DG; Thorpe SR; Baynes JW
    J Biol Chem; 1987 May; 262(15):7207-12. PubMed ID: 3584112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buffer-free therapeutic antibody preparations provide a viable alternative to conventionally buffered solutions: from protein buffer capacity prediction to bioprocess applications.
    Bahrenburg S; Karow AR; Garidel P
    Biotechnol J; 2015 Apr; 10(4):610-22. PubMed ID: 25641961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of glycation and its impact on antigen binding.
    Mo J; Jin R; Yan Q; Sokolowska I; Lewis MJ; Hu P
    MAbs; 2018 Apr; 10(3):406-415. PubMed ID: 29436927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer.
    Amaral Silva D; Al-Gousous J; Davies NM; Bou Chacra N; Webster GK; Lipka E; Amidon G; Löbenberg R
    Eur J Pharm Biopharm; 2019 Sep; 142():8-19. PubMed ID: 31195131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved process intermediate stability through the identification and elimination of reactive glycation residues - a monoclonal antibody case study.
    Bosley A; Cook K; Lin S; Robbins D
    Bioengineered; 2022 Jun; 13(6):14402-14412. PubMed ID: 35757891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low pK
    Xu X; O'Callaghan JA; Guarnero Z; Qiu H; Li N; Potocky T; Kamen DE; Graham KS; Shameem M; Yang TC
    Biophys J; 2022 Mar; 121(6):1081-1093. PubMed ID: 35122736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of nonenzymatic glycation on a monoclonal antibody.
    Brady LJ; Martinez T; Balland A
    Anal Chem; 2007 Dec; 79(24):9403-13. PubMed ID: 17985928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study in glycation of a therapeutic recombinant humanized monoclonal antibody: where it is, how it got there, and how it affects charge-based behavior.
    Quan C; Alcala E; Petkovska I; Matthews D; Canova-Davis E; Taticek R; Ma S
    Anal Biochem; 2008 Feb; 373(2):179-91. PubMed ID: 18158144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
    Garidel P; Pevestorf B; Bahrenburg S
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the acidic species of a monoclonal antibody using free flow electrophoresis fractionation and mass spectrometry.
    Liu S; Madren S; Feng P; Sosic Z
    J Pharm Biomed Anal; 2020 Jun; 185():113217. PubMed ID: 32145540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developability studies before initiation of process development: improving manufacturability of monoclonal antibodies.
    Yang X; Xu W; Dukleska S; Benchaar S; Mengisen S; Antochshuk V; Cheung J; Mann L; Babadjanova Z; Rowand J; Gunawan R; McCampbell A; Beaumont M; Meininger D; Richardson D; Ambrogelly A
    MAbs; 2013; 5(5):787-94. PubMed ID: 23883920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic modeling as a tool to understand the influence of cell culture process parameters on the glycation of monoclonal antibody biotherapeutics.
    Agarwal N; Mason A; Pradhan R; Kemper J; Bosley A; Serfiotis-Mitsa D; Wang J; Lindo V; Ahuja S; Hatton D; Savery J; Miro-Quesada G
    Biotechnol Prog; 2019 Sep; 35(5):e2865. PubMed ID: 31180183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation endproducts in food and their effects on health.
    Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
    Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion.
    Wang Y; Li X; Liu YH; Richardson D; Li H; Shameem M; Yang X
    MAbs; 2016; 8(8):1477-1486. PubMed ID: 27598507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using lysine-reactive fluorescent dye for surface characterization of a mAb.
    Lei M; Kao YH; Schöneich C
    J Pharm Sci; 2015 Mar; 104(3):995-1004. PubMed ID: 25538029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.